Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.67
+0.02790.08%
Post-market: 34.680.0109+0.03%16:10 EDT
Volume:1K
Turnover:37.47K
Market Cap:44.20M
PE:- -
High:34.68
Open:34.59
Low:34.53
Close:34.64
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.31
T/O Rate:0.08%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
10 hours ago

Ascendis Pharma Director Lars Holtug Disposes of 236 Shares Worth $62,337.59

Reuters
·
10 hours ago

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
12 hours ago

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
13 hours ago

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
14 hours ago

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Yesterday

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Yesterday

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Yesterday

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Yesterday

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Yesterday

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Yesterday

Ascendis Pharma is Maintained at Outperform by Oppenheimer

Dow Jones
·
Yesterday

Ascendis Pharma a/S : Oppenheimer Raises Target Price to $312 from $304

THOMSON REUTERS
·
Sep 02

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

Rhythm Pharma CFO Hunter C. Smith Disposes of Common Shares Worth $6.61 Million

Reuters
·
Sep 02

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
Sep 02

Ascendis Pharma Price Target Maintained with a $327.00/Share by Wedbush

Dow Jones
·
Sep 01